Medical Excellence Capital

About The Fund

Medical Excellence Capital (MEC) is a venture capital firm specializing in early-stage investments in the healthcare and life sciences sectors. Founded by John Prufeta in 2020, MEC operates with seasoned venture capital investors, company creators, and operators with decades of experience working together, boasting a successful track record across multiple sectors within healthcare investment and operating environments. The firm's focus extends across various industries, including Biotech, Fintech and Financial Services, HealthTech and Fitness, Cloud Services and Infrastructure, Medical Devices and Hospital Services, and Healthcare and Wellness. MEC's investment strategy hones in on Seed to Series B stages, with an investment range starting at $100,000, a sweet spot around $1,500,000, and a ceiling of $5,000,000. MEC prides itself on a purpose-built team dedicated to supporting the most promising healthcare research and innovation in the U.S. by providing more than just funding. They offer insights and strategic guidance derived from a wealth of operational and consulting experience. Their leadership includes John Prufeta, who also serves as Chairman of The Medical Excellence Foundation, Eric Heil, a venture capitalist with significant healthcare industry experience, and other notable managing partners like Kim Kamdar, PhD, with expertise in therapeutic startups, and Brian Halak, PhD, with a history of creating and investing in successful healthcare companies. MEC is partnered with scientific advisors who are innovators in fields like regenerative medicine and gene therapy, further aiding in opportunity evaluation and value addition to portfolio companies. They aim to forge a new path in healthcare investing, prioritizing both patient outcomes and company success.